Investor Update

Basel, 01 July 2011

Anti-Cancer Agent, Tarceva® Obtained Approval for Additional Indication of “Pancreatic Cancer Not Amenable to Curative Resection“ and Measures for Proper Use

Dear Investor,

Please find attached a press release by Chugai.

Do not hesitate to contact us for any further questions.